May 2023
1. DOI T, Langsted A, Nordestgaard BG
   Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality.
   Atherosclerosis. 2023 May 13:S0021-9150(23)00204.
   

   >> Share

   
   
2. KUEHNEMUND L, Lange SA, Feld J, Padberg JS, et al
   Sex disparities in guideline-recommended therapies and outcomes after ST-elevation myocardial infarction in a contemporary nationwide cohort of patients over an eight-year period.
   Atherosclerosis. 2023;375:30-37.
   

   >> Share

   
   
3. KUMAR A, Stillman AE, Chatzizisis YS
   Coronary plaque phenotyping with cardiac CTA: Separating the signal from the noise.
   Atherosclerosis. 2023;373:66-68.
   

   >> Share

   
   
4. LEMIEUX I, Despres JP
   Weight gain with age and coronary atherosclerosis: Only the tip of a deadly iceberg.
   Atherosclerosis. 2023;373:55-57.
   

   >> Share

   
   
5. YANG S, Lesina K, Doh JH, Jegere S, et al
   Long-term prognostic implications of hemodynamic and plaque assessment using coronary CT angiography.
   Atherosclerosis. 2023;373:58-65.
   

   >> Share

   
   
6. BERGSTROM G, Rosengren A, Bacsovics Brolin E, Brandberg J, et al
   Body weight at age 20 and in midlife is more important than weight gain for coronary atherosclerosis: Results from SCAPIS.
   Atherosclerosis. 2023;373:46-54.
   

   >> Share

   
   April 2023
7. NAYFEH M, Ahmed AI, Alahdab F, Al Rifai M, et al
   No contrast? No problem! Value in assessing pericoronary fat in non-contrast studies.
   Atherosclerosis. 2023;370:3-4.
   

   >> Share

   
   
8. TAKAHASHI D, Fujimoto S, Nozaki YO, Kudo A, et al
   Validation and clinical impact of novel pericoronary adipose tissue measurement on ECG-gated non-contrast chest CT.
   Atherosclerosis. 2023;370:18-24.
   

   >> Share

   
   March 2023
9. YANG XH, Zhang BL, Cheng Y, Fu SK, et al
   Association of remnant cholesterol with risk of cardiovascular disease events, stroke, and mortality: A systemic review and meta-analysis.
   Atherosclerosis. 2023;371:21-31.
   

   >> Share

   
   
10. TADA H, Nomura A, Nohara A, Usui S, et al
    Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia.
    Atherosclerosis. 2023 Mar 17:S0021-9150(23)00103.
    

    >> Share

    
    
11. MOK Y, Wang F, Ballew SH, Menez S, et al
    Kidney function, bone-mineral metabolism markers, and calcification of coronary arteries, aorta, and cardiac valves in older adults.
    Atherosclerosis. 2023;368:35-43.
    

    >> Share

    
    February 2023
12. KATRA P, Hennings V, Nilsson J, Engstrom G, et al
    Plasma levels of CCL21, but not CCL19, independently predict future coronary events in a prospective population-based cohort.
    Atherosclerosis. 2023;366:1-7.
    

    >> Share

    
    
13. DI GIOVANNI G, Kataoka Y, Bubb K, Nelson AJ, et al
    Impact of lipid lowering on coronary atherosclerosis moving from the lumen to the artery wall.
    Atherosclerosis. 2023;367:8-14.
    

    >> Share

    
    
14. FENG X, Zhang C, Huang X, Liu J, et al
    Machine learning improves mortality prediction in three-vessel disease.
    Atherosclerosis. 2023;367:1-7.
    

    >> Share

    
    January 2023
15. MONTONE RA, Rinaldi R, Bonanni A, Severino A, et al
    Impact of air pollution on ischemic heart disease: Evidence, mechanisms, clinical perspectives.
    Atherosclerosis. 2023;366:22-31.
    

    >> Share

    
    
16. TSABAN G, Peles I, Barrett O, Abramowitz Y, et al
    Nonobstructive coronary atherosclerosis is associated with adverse prognosis among patients diagnosed with myocardial infarction without obstructive coronary arteries.
    Atherosclerosis. 2023;366:8-13.
    

    >> Share

    
    
17. DORAJOO R, Ihsan MO, Liu W, Lim HY, et al
    Vascular smooth muscle cells in low SYNTAX scores coronary artery disease exhibit proinflammatory transcripts and proteins correlated with IL1B activation.
    Atherosclerosis. 2023;365:15-24.
    

    >> Share

    
    December 2022
18. TAY KY, Wu KX, Chioh FWJ, Autio MI, et al
    Trans-interaction of risk loci 6p24.1 and 10q11.21 is associated with endothelial damage in coronary artery disease.
    Atherosclerosis. 2022;362:11-22.
    

    >> Share

    
    
19. LIND L, Markstad H, Ahlstrom H, Angeras O, et al
    Obesity is associated with coronary artery stenosis independently of metabolic risk factors: The population-based SCAPIS study.
    Atherosclerosis. 2022;362:1-10.
    

    >> Share

    
    
20. GOWDA SGB, Gowda D, Hou F, Chiba H, et al
    Temporal lipid profiling in the progression from acute to chronic heart failure in mice and ischemic human hearts.
    Atherosclerosis. 2022;363:30-41.
    

    >> Share

    
    
21. MEHTA PK, Huang J, Levit RD, Malas W, et al
    Ischemia and no obstructive coronary arteries (INOCA): A narrative review.
    Atherosclerosis. 2022;363:8-21.
    

    >> Share

    
    
22. JINNOUCHI H, Sakakura K, Taniguchi Y, Tsukui T, et al
    Impact of ultrasound reverberation in calcified coronary arteries: Intravascular ultrasound study.
    Atherosclerosis. 2022;363:1-7.
    

    >> Share

    
    
23. ZIERFUSS B, Hobaus C, Feldscher A, Hannes A, et al
    Lipoprotein (a) and long-term outcome in patients with peripheral artery disease undergoing revascularization.
    Atherosclerosis. 2022;363:94-101.
    

    >> Share

    
    
24. RIKHI R, Hammoud A, Ashburn N, Snavely AC, et al
    Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Atherosclerosis. 2022;363:102-108.
    

    >> Share

    
    November 2022
25. AHN HJ, Lee H, Park HE, Han D, et al
    Changes in metabolic syndrome burden and risk of coronary artery calcification progression in statin-naive young adults.
    Atherosclerosis. 2022;360:27-33.
    

    >> Share

    
    
26. OKADA K, Kikuchi S, Kuji S, Nakayama N, et al
    Impact of early intervention with alogliptin on coronary plaque regression and stabilization in patients with acute coronary syndromes.
    Atherosclerosis. 2022;360:1-7.
    

    >> Share

    
    
27. SEKIMOTO T, Mori H, Koba S, Arai T, et al
    Clinical features and lipid profiles of plaque erosion over lipid-rich plaque versus fibrous plaque in patients with acute coronary syndrome.
    Atherosclerosis. 2022;360:47-52.
    

    >> Share

    
    October 2022
28. YUAN D, Wang P, Jia S, Zhang C, et al
    Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention.
    Atherosclerosis. 2022 Oct 25. pii: S0021-9150(22)01495.
    

    >> Share

    
    
29. TESCHE C, Bauer MJ, Straube F, Rogowski S, et al
    Association of epicardial adipose tissue with coronary CT angiography plaque parameters on cardiovascular outcome in patients with and without diabetes mellitus.
    Atherosclerosis. 2022 Oct 17. pii: S0021-9150(22)01477.
    

    >> Share

    
    
30. WU S, Yang YM, Zhu J, Xu W, et al
    Impact of glycemic gap on 30-day adverse outcomes in patients with acute ST-segment elevation myocardial infarction.
    Atherosclerosis. 2022;360:34-41.
    

    >> Share

    
    
31. SUN Y, Zhang H, Wang B, Chen C, et al
    Joint exposure to positive affect, life satisfaction, broad depression, and neuroticism and risk of cardiovascular diseases: A prospective cohort study.
    Atherosclerosis. 2022;359:44-51.
    

    >> Share

    
    September 2022
32. DE MARCHIS GM, Dittrich TD, Malik R, Zietz AV, et al
    Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke.
    Atherosclerosis. 2022 Sep 26. pii: S0021-9150(22)01433.
    

    >> Share

    
    
33. NONG JC, You W, Xu T, Meng PN, et al
    Dynamic natural morphologies and component changes in nonculprit subclinical atherosclerosis in patients with acute coronary syndrome at 1-year follow-up and clinical significance at 3-year follow-up.
    Atherosclerosis. 2022;356:1-8.
    

    >> Share

    
    August 2022
34. SCHIANO C, Balbi C, Burrello J, Ruocco A, et al
    De novo DNA methylation induced by circulating extracellular vesicles from acute coronary syndrome patients.
    Atherosclerosis. 2022;354:41-52.
    

    >> Share

    
    
35. CICERO AFG, Salvetti M
    Peripheral artery disease: A highly prevalent untreated and uncontrolled independent cardiovascular disease.
    Atherosclerosis. 2022;354:55-56.
    

    >> Share

    
    
36. KUMAR R, Bainey KR
    Percutaneous coronary intervention with peripheral artery disease in the contemporary era: Still life or limb?
    Atherosclerosis. 2022;355:45-47.
    

    >> Share

    
    
37. PINXTERHUIS TH, Ploumen EH, Zocca P, Doggen CJM, et al
    Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials.
    Atherosclerosis. 2022;355:52-59.
    

    >> Share

    
    July 2022
38. KIM C, Choi DW, Lee SJ, Suh Y, et al
    Benefit and risk of prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with chronic kidney disease: A nationwide cohort study.
    Atherosclerosis. 2022;352:69-75.
    

    >> Share

    
    
39. ALFADDAGH A, Kapoor K, Dardari ZA, Bhatt DL, et al
    Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention.
    Atherosclerosis. 2022;353:11-19.
    

    >> Share

    
    
40. AL RIFAI M, Ahmed AI, Al-Mallah MH
    Evaluating coronary atherosclerosis progression among South Asians.
    Atherosclerosis. 2022;353:30-32.
    

    >> Share

    
    
41. BHATIA HS, Lin F, Thomas IC, Denenberg J, et al
    Coronary artery calcium incidence and changes using direct plaque measurements: The MASALA study.
    Atherosclerosis. 2022;353:41-46.
    

    >> Share

    
    
42. POST WS, Haberlen SA, Witt MD, Zhang L, et al
    Suboptimal HIV suppression is associated with progression of coronary artery stenosis: The Multicenter AIDS Cohort Study (MACS) longitudinal coronary CT angiography study.
    Atherosclerosis. 2022;353:33-40.
    

    >> Share

    
    June 2022
43. KYTO V, Saraste A, Tornio A
    Early statin use and cardiovascular outcomes after myocardial infarction: A population-based case-control study.
    Atherosclerosis. 2022;354:8-14.
    

    >> Share

    
    
44. CLARKE R, Hammami I, Sherliker P, Valdes-Marquez E, et al
    Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study.
    Atherosclerosis. 2022;354:15-22.
    

    >> Share

    
    
45. BOAKYE E, Dardari Z, Obisesan OH, Osei AD, et al
    Sex-and race-specific burden of aortic valve calcification among older adults without overt coronary heart disease: The Atherosclerosis Risk in Communities Study.
    Atherosclerosis. 2022 Jun 13. pii: S0021-9150(22)00290.
    

    >> Share

    
    
46. CALBUREAN PA, Grebenisan P, Nistor IA, Pal K, et al
    Prediction of 3-year all-cause and cardiovascular cause mortality in a prospective percutaneous coronary intervention registry: Machine learning model outperforms conventional clinical risk scores.
    Atherosclerosis. 2022;350:33-40.
    

    >> Share

    
    
47. ROESNER C, Goeller M, Raaz-Schrauder D, Dey D, et al
    Differences of inflammatory cytokine profile in patients with vulnerable plaque: A coronary CTA study.
    Atherosclerosis. 2022;350:25-32.
    

    >> Share

    
    
48. GORDIN D, Bjornstad P, van Raalte DH
    Lipids in CKD: What do we actually know?
    Atherosclerosis. 2022;350:97-99.
    

    >> Share

    
    
49. SORENSEN IM, Bisgaard LS, Bjergfelt SS, Ballegaard EL, et al
    The metabolic signature of cardiovascular disease and arterial calcification in patients with chronic kidney disease.
    Atherosclerosis. 2022;350:109-118.
    

    >> Share

    
    
50. GROENLAND EH, Heidemann BE, van der Laan SW, van Setten J, et al
    Genetic variants associated with low-density lipoprotein cholesterol and systolic blood pressure and the risk of recurrent cardiovascular disease in patients with established vascular disease.
    Atherosclerosis. 2022;350:102-108.
    

    >> Share

    
    May 2022
51. SCHNITZER F, Forer L, Schonherr S, Gieger C, et al
    Association between a polygenic and family risk score on the prevalence and incidence of myocardial infarction in the KORA-F3 study.
    Atherosclerosis. 2022;352:10-17.
    

    >> Share

    
    
52. WELSH RC, Kay R, Bainey KR
    Evaluation and management of chronic kidney disease patients with stable ischemic heart disease.
    Atherosclerosis. 2022 May 16. pii: S0021-9150(22)00241.
    

    >> Share

    
    
53. MATSUSHITA K, Gao Y, Sang Y, Ballew SH, et al
    Comparative mortality according to peripheral artery disease and coronary heart disease/stroke in the United States.
    Atherosclerosis. 2022 May 8. pii: S0021-9150(22)00221.
    

    >> Share

    
    
54. WOLTERS FJ, Hilal S, Leening MJG, Kavousi M, et al
    Plasma amyloid-beta40 in relation to subclinical atherosclerosis and cardiovascular disease: A population-based study.
    Atherosclerosis. 2022;348:44-50.
    

    >> Share

    
    
55. DANG AT, Turner AW, Lau P, Mohottalage D, et al
    A novel anti-inflammatory role links the CARS2 locus to protection from coronary artery disease.
    Atherosclerosis. 2022;348:8-15.
    

    >> Share

    
    
56. MATSUOKA S, Kaneko H, Okada A, Itoh H, et al
    Association of retinal atherosclerosis assessed using Keith-Wagener-Barker system with incident heart failure and other atherosclerotic cardiovascular disease: Analysis of 319,501 individuals from the general population.
    Atherosclerosis. 2022;348:68-74.
    

    >> Share

    
    
57. GRUNEIS R, Lamina C, Di Maio S, Schonherr S, et al
    The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A.
    Atherosclerosis. 2022;349:151-159.
    

    >> Share

    
    
58. LI Q, Chen Y, Yu L, Zhu L, et al
    The relationship between lipoprotein(a) and cardiovascular events in acute coronary syndrome patients with and without chronic kidney disease.
    Atherosclerosis. 2022;349:204-210.
    

    >> Share

    
    
59. LEE H, Park KS, Jeon YJ, Park EJ, et al
    Lipoprotein(a) and subclinical coronary atherosclerosis in asymptomatic individuals.
    Atherosclerosis. 2022;349:190-195.
    

    >> Share

    
    April 2022
60. CHO IY, Yoo JE, Han K, Kim D, et al
    Frequent drinking is more predictive of ischemic stroke than binge drinking, but not of myocardial infarction.
    Atherosclerosis. 2022;350:65-72.
    

    >> Share

    
    
61. TENG H, Gao Y, Wu C, Zhang H, et al
    Prevalence and patient characteristics of familial hypercholesterolemia in a Chinese population aged 35-75 years: Results from China PEACE Million Persons Project.
    Atherosclerosis. 2022;350:58-64.
    

    >> Share

    
    
62. NAKAMURA H, Kataoka Y, Nicholls SJ, Puri R, et al
    Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry.
    Atherosclerosis. 2022 Apr 10. pii: S0021-9150(22)00166.
    

    >> Share

    
    
63. JUKEMA RA, de Winter RW, van Diemen PA, Driessen RS, et al
    The relation of RAAS activity and endothelin-1 levels to coronary atherosclerotic burden and microvascular dysfunction in chest pain patients.
    Atherosclerosis. 2022;347:47-54.
    

    >> Share

    
    
64. AHMED AI, Raggi P, Al-Mallah MH
    Primary vs. secondary prevention and coronary artery calcium: Shades of grey.
    Atherosclerosis. 2022;347:68-69.
    

    >> Share

    
    
65. DZAYE O, Razavi AC, Michos ED, Mortensen MB, et al
    Coronary artery calcium scores indicating secondary prevention level risk: Findings from the CAC consortium and FOURIER trial.
    Atherosclerosis. 2022;347:70-76.
    

    >> Share

    
    
66. MAURICIO R, Singh K, Sanghavi M, Ayers CR, et al
    Soluble Fms-like tyrosine kinase-1 (sFlt-1) is associated with subclinical and clinical atherosclerotic cardiovascular disease: The Dallas Heart Study.
    Atherosclerosis. 2022;346:46-52.
    

    >> Share

    
    
67. KATSIKI N, Raggi P, Korosoglou G
    Carotid ultrasound and coronary calcium for the prediction of incident cardiac disease in asymptomatic individuals: A further step towards precision medicine especially in women?
    Atherosclerosis. 2022;346:79-81.
    

    >> Share

    
    
68. YAMAGUCHI M, Hoshino M, Sugiyama T, Kanaji Y, et al
    Association of near-infrared spectroscopy-defined lipid rich plaque with lesion morphology and peri-coronary inflammation on computed tomography angiography.
    Atherosclerosis. 2022;346:109-116.
    

    >> Share

    
    March 2022
69. CHO IY, Chang Y, Sung E, Kim Y, et al
    Fasting ketonuria is inversely associated with coronary artery calcification in non-diabetic individuals.
    Atherosclerosis. 2022;348:1-7.
    

    >> Share

    
    
70. LESZEK A, Poli L, Zbinden S, Godoy LC, et al
    Outcomes with revascularization and medical therapy in patients with coronary disease and chronic kidney disease: A meta-analysis.
    Atherosclerosis. 2022 Mar 4. pii: S0021-9150(22)00106.
    

    >> Share

    
    
71. CHRISTENSEN DM, Strange JE, Phelps M, Schjerning AM, et al
    Age- and sex-specific trends in the incidence of myocardial infarction in Denmark, 2005 to 2021.
    Atherosclerosis. 2022;346:63-67.
    

    >> Share

    
    
72. BAJAJ R, Eggermont J, Grainger SJ, Raber L, et al
    Machine learning for atherosclerotic tissue component classification in combined near-infrared spectroscopy intravascular ultrasound imaging: Validation against histology.
    Atherosclerosis. 2022;345:15-25.
    

    >> Share

    
    
73. ASZTALOS BF, Hauser TH, Goldfine AB, Welty FK, et al
    The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity.
    Atherosclerosis. 2022;345:1-6.
    

    >> Share

    
    
74. KOBO O, Saada M, Laanmets P, Karageorgiev D, et al
    Impact of peripheral artery disease on prognosis after percutaneous coronary intervention: Outcomes from the multicenter prospective e-ULTIMASTER registry.
    Atherosclerosis. 2022;344:71-77.
    

    >> Share

    
    
75. KOSHY AN, Nerlekar N, Gow PJ, Lim R, et al
    A prospective natural history study of coronary atherosclerosis following liver transplantation.
    Atherosclerosis. 2022;344:40-48.
    

    >> Share

    
    
76. KUNIO M, Gardecki JA, Watanabe K, Nishimiya K, et al
    Histopathological correlation of near infrared autofluorescence in human cadaver coronary arteries.
    Atherosclerosis. 2022;344:31-39.
    

    >> Share

    
    
77. FUJIMOTO D, Otake H, Kawamori H, Toba T, et al
    Cholesterol uptake capacity: A new measure of high-density lipoprotein functionality as a predictor of subsequent revascularization in patients undergoing percutaneous coronary intervention.
    Atherosclerosis. 2022;345:44-50.
    

    >> Share

    
    February 2022
78. PASZEK E, Pociask E, Zabczyk M, Piorkowski A, et al
    Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients.
    Atherosclerosis. 2022 Feb 11. pii: S0021-9150(22)00078.
    

    >> Share

    
    
79. STONE PH, Coskun AU
    Coronary angiography-based shear stress computation to identify high-risk coronary artery plaques: Are we there yet?
    Atherosclerosis. 2022;342:25-27.
    

    >> Share

    
    
80. WENTZEL JJ, Papafaklis MI, Antoniadis AP, Takahashi S, et al
    Sex-related differences in plaque characteristics and endothelial shear stress related plaque-progression in human coronary arteries.
    Atherosclerosis. 2022;342:9-18.
    

    >> Share

    
    
81. HULTEN EA, Gallagher RM
    Coronary revascularization for patients with non-ST elevation myocardial infarction and chronic kidney disease: Better three hours too soon than a minute too late?
    Atherosclerosis. 2022 Feb 1. pii: S0021-9150(22)00042.
    

    >> Share

    
    January 2022
82. GUDMUNDSSON EF, Bjornsdottir G, Sigurdsson S, Andersen K, et al
    Carotid plaque is strongly associated with coronary artery calcium and predicts incident coronary heart disease in a population-based cohort.
    Atherosclerosis. 2022 Jan 23. pii: S0021-9150(22)00043.
    

    >> Share

    
    
83. YOSHIDA Y, Chen Z, Baudier RL, Krousel-Wood M, et al
    Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women.
    Atherosclerosis. 2022;344:13-19.
    

    >> Share

    
    
84. HE X, Dong B, Liang W, Wu Y, et al
    Ischemic risk in patients with heart failure with preserved ejection fraction: A post hoc analysis of the TOPCAT data.
    Atherosclerosis. 2022;344:1-6.
    

    >> Share

    
    
85. ANNEMA W, Gawinecka J, Muendlein A, Saely CH, et al
    Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease.
    Atherosclerosis. 2022;341:27-33.
    

    >> Share

    
    
86. LEE YH, Tsai TH, Chen JH, Huang CJ, et al
    Machine learning of treadmill exercise test to improve selection for testing for coronary artery disease.
    Atherosclerosis. 2022;340:23-27.
    

    >> Share

    
    
87. MA WF, Hodonsky CJ, Turner AW, Wong D, et al
    Enhanced single-cell RNA-seq workflow reveals coronary artery disease cellular cross-talk and candidate drug targets.
    Atherosclerosis. 2022;340:12-22.
    

    >> Share

    
    December 2021
88. ZHANG H, Yi M, Wang Y, Zhang Y, et al
    Air pollution and recurrence of cardiovascular events after ST-segment elevation myocardial infarction.
    Atherosclerosis. 2021;342:1-8.
    

    >> Share

    
    
89. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Outcome of early versus delayed invasive strategy in patients with non-ST-segment elevation myocardial infarction and chronic kidney disease not on dialysis.
    Atherosclerosis. 2021 Dec 1. pii: S0021-9150(21)01463.
    

    >> Share

    
    
90. ZEB I, Jorgensen NW, Blumenthal RS, Burke GL, et al
    Association of inflammatory markers and lipoprotein particle subclasses with progression of coronary artery calcium: The multi-ethnic study of atherosclerosis.
    Atherosclerosis. 2021;339:27-34.
    

    >> Share

    
    
91. DI GIORGI N, Michelucci E, Smit JM, Scholte AJHA, et al
    A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome.
    Atherosclerosis. 2021;339:1-11.
    

    >> Share

    
    
92. DZAYE O, Berning P, Dardari ZA, Berman DS, et al
    Coronary artery calcium is associated with long-term mortality from lung cancer: Results from the Coronary Artery Calcium Consortium.
    Atherosclerosis. 2021;339:48-54.
    

    >> Share

    
    November 2021
93. LOH WJ, Chang X, Aw TC, Phua SK, et al
    Lipoprotein(a) as predictor of coronary artery disease and myocardial infarction in a multi-ethnic Asian population.
    Atherosclerosis. 2021 Nov 26. pii: S0021-9150(21)01446.
    

    >> Share

    
    
94. CANDREVA A, Pagnoni M, Rizzini ML, Mizukami T, et al
    Risk of myocardial infarction based on endothelial shear stress analysis using coronary angiography.
    Atherosclerosis. 2021 Nov 16. pii: S0021-9150(21)01437.
    

    >> Share

    
    
95. VERDOIA M, De Luca G
    Reply to: "Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead".
    Atherosclerosis. 2021;336:49-50.
    

    >> Share

    
    
96. ZUIN M, Rigatelli G, Zuliani G, Roncon L, et al
    Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead.
    Atherosclerosis. 2021;336:48.
    

    >> Share

    
    
97. WANG FM, Yang C, Ballew SH, Kalbaugh CA, et al
    Ankle-brachial index and subsequent risk of incident and recurrent cardiovascular events in older adults: The Atherosclerosis Risk in Communities (ARIC) study.
    Atherosclerosis. 2021;336:39-47.
    

    >> Share

    
    October 2021
98. MAHENDIRAN T, Klingenberg R, Nanchen D, Gencer B, et al
    CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patients.
    Atherosclerosis. 2021;335:77-83.
    

    >> Share

    
    
99. MARTINEZ-CEBALLOS MA, Sinning Rey JC, Alzate-Granados JP, Mendoza-Pinto C, et al
    Coronary calcium in autoimmune diseases: A systematic literature review and meta-analysis.
    Atherosclerosis. 2021;335:68-76.
    

    >> Share

    
    
100. KIM H, Park JT, Lee J, Jung JY, et al
     The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney disease.
     Atherosclerosis. 2021;335:53-61.
     

     >> Share

     
     
101. DOBIASOVA M
     Correspondence to: "Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors".
     Atherosclerosis. 2021;335:148.
     

     >> Share

     
     
102. NEGRINI S, von Eckardstein A
     Reply to: "Correspondence to: "Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors"".
     Atherosclerosis. 2021;335:149.
     

     >> Share

     
     
103. VENKATARAMAN P, Huynh Q, Nicholls SJ, Stanton T, et al
     Impact of a coronary artery calcium-guided statin treatment protocol on cardiovascular risk at 12 months: Results from a pragmatic, randomised controlled trial.
     Atherosclerosis. 2021;334:57-65.
     

     >> Share

     
     
104. HAQUE W, Grandhi GR, Kanaya AM, Kandula NR, et al
     Implications of the 2019 American College of Cardiology/American Heart Association Primary Prevention Guidelines and potential value of the coronary artery calcium score among South Asians in the US: The Mediators of Atherosclerosis in South Asians Li
     Atherosclerosis. 2021;334:48-56.
     

     >> Share

     
     
105. BAMBAGIONI G, Di Mario C, Torguson R, Demola P, et al
     Lipid-rich plaques detected by near-infrared spectroscopy predict coronary events irrespective of age: A Lipid Rich Plaque sub-study.
     Atherosclerosis. 2021;334:17-22.
     

     >> Share

     
     
106. AHMED AI, Han Y, Al Rifai M, Alnabelsi T, et al
     Added prognostic value of plaque burden to computed tomography angiography and myocardial perfusion imaging.
     Atherosclerosis. 2021;334:9-16.
     

     >> Share

     
     September 2021
107. KRISTIANSEN O, Sverre E, Peersen K, Fagerland MW, et al
     The relationship between directly measured statin adherence, self-reported adherence measures and cholesterol levels in patients with coronary heart disease.
     Atherosclerosis. 2021;336:23-29.
     

     >> Share

     
     
108. LIU Y, Liu S, Zhao Z, Song X, et al
     Phenylacetylglutamine is associated with the degree of coronary atherosclerotic severity assessed by coronary computed tomographic angiography in patients with suspected coronary artery disease.
     Atherosclerosis. 2021;333:75-82.
     

     >> Share

     
     
109. AGBAEDENG TA, Noubiap JJ, Mofo Mato EP, Chew DP, et al
     Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data.
     Atherosclerosis. 2021;333:48-55.
     

     >> Share

     
     
110. ALI HJ, Al-Mallah MH
     Time for sex specific atherosclerosis risk prediction.
     Atherosclerosis. 2021;333:87-88.
     

     >> Share

     
     
111. PEPE M, Napoli G, Carulli E, Moscarelli M, et al
     Autoimmune diseases in patients undergoing percutaneous coronary intervention: A risk factor for in-stent restenosis?
     Atherosclerosis. 2021;333:24-31.
     

     >> Share

     
     
112. USUI E, Matsumura M, Mintz GS, Zhou Z, et al
     Clinical outcomes of low-intensity area without attenuation and cholesterol crystals in non-culprit lesions assessed by optical coherence tomography.
     Atherosclerosis. 2021;332:41-47.
     

     >> Share

     
     
113. VERNON ST, Kott KA, Hansen T, Zhang KJ, et al
     Coronary artery disease burden in women poorly explained by traditional risk factors: Sex disaggregated analyses from the BioHEART-CT study.
     Atherosclerosis. 2021;333:100-107.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share